Suppression of Tumorigenicity 14 抗体
Recommended next Filters:
您想试用我们的人工智能搜索吗?
57 results :
Latest Publications for our Suppression of Tumorigenicity 14 抗体
: "Developmental mechanisms driving complex tooth shape in reptiles." in: Developmental dynamics : an official publication of the American Association of Anatomists, Vol. 249, Issue 4, pp. 441-464, (2020) (PubMed).: "Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis." in: PLoS genetics, Vol. 15, Issue 1, pp. e1007882, (2019) (PubMed).
: "Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis." in: The Journal of biological chemistry, Vol. 292, Issue 26, pp. 10801-10812, (2017) (PubMed).
: "Matriptase zymogen supports epithelial development, homeostasis and regeneration." in: BMC biology, Vol. 15, Issue 1, pp. 46, (2017) (PubMed).
: "Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin." in: The Journal of biological chemistry, Vol. 291, Issue 6, pp. 2577-82, (2016) (PubMed).
: "Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling." in: Nature communications, Vol. 6, pp. 6776, (2015) (PubMed).
: "Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors." in: Oncogene, Vol. 34, Issue 35, pp. 4664-72, (2015) (PubMed).
: "Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma." in: The Journal of investigative dermatology, Vol. 135, Issue 9, pp. 2283-91, (2015) (PubMed).
: "Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survival." in: PLoS genetics, Vol. 10, Issue 7, pp. e1004470, (2015) (PubMed).
: "Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium." in: Journal of virology, Vol. 87, Issue 8, pp. 4237-51, (2013) (PubMed).
Aliases for Suppression of Tumorigenicity 14 抗体
suppression of tumorigenicity 14 (ST14) 抗体amyloid beta precursor like protein 2 (APLP2) 抗体
suppression of tumorigenicity 14 L homeolog (st14.L) 抗体
suppression of tumorigenicity 14 (colon carcinoma) (St14) 抗体
suppression of tumorigenicity 14 (St14) 抗体
suppression of tumorigenicity 14 (colon carcinoma) a (st14a) 抗体
suppression of tumorigenicity 14 (colon carcinoma) b (st14b) 抗体
suppression of tumorigenicity 14 S homeolog (st14.S) 抗体
APLP-2 抗体
APPH 抗体
APPL2 抗体
CDEBP 抗体
Epithin 抗体
HAI 抗体
hai 抗体
matriptase 抗体
mCAP3 抗体
MT-SP1 抗体
mt-sp1 抗体
MTSP1 抗体
mtsp1 抗体
PRSS14 抗体
prss14 抗体
Prss14 抗体
SNC19 抗体
snc19 抗体
st14 抗体
st14-a 抗体
st14-b 抗体
st14a 抗体
st14b 抗体
TADG15 抗体
tadg15 抗体
tmprss1 抗体
TMPRSS14 抗体
Tmprss14 抗体
wu:fi41g07 抗体
wu:fl72f01 抗体
XMT-SP1 抗体
zgc:136950 抗体
zgc:152656 抗体
zgc:152657 抗体
zgc:152947 抗体